ENTASIS THERAPEUTICS HLDGS I's ticker is ETTX and the CUSIP is 293614103. A total of 20 filers reported holding ENTASIS THERAPEUTICS HLDGS I in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $122,000 | -52.5% | 49,478 | -60.7% | 0.00% | – |
Q3 2020 | $257,000 | +40.4% | 125,848 | +342.8% | 0.00% | – |
Q2 2019 | $183,000 | -13.3% | 28,419 | -9.1% | 0.00% | – |
Q1 2019 | $211,000 | +51.8% | 31,250 | -8.5% | 0.00% | – |
Q4 2018 | $139,000 | -83.9% | 34,143 | -57.0% | 0.00% | -100.0% |
Q3 2018 | $864,000 | – | 79,437 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Novo Holdings A/S | 2,181,843 | $5,760,000 | 0.38% |
FRAZIER MANAGEMENT LLC | 1,049,953 | $2,775,000 | 0.32% |
Sofinnova Investments, Inc. | 1,180,178 | $3,119,000 | 0.29% |
Eventide Asset Management | 879,541 | $2,131,000 | 0.07% |
TPG Group Holdings (SBS) Advisors, Inc. | 1,020,748 | $2,698,000 | 0.06% |
Blackstone Inc. | 1,623,405 | $4,286,000 | 0.03% |
Granahan Investment Management | 154,658 | $409,000 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 35,000 | $89,000 | 0.00% |
Janney Montgomery Scott LLC | 51,555 | $136,000 | 0.00% |
Raymond James Financial Services Advisors, Inc. | 20,200 | $53,000 | 0.00% |